-
Clinical Pharmacology: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Adverse drug effects in hospitalized elderly: Data from the Healthcare Cost and Utilization Project
Original Research
(2801) Views (881) Full article downloads
Authors: Tatyana Shamliyan
Published Date May 2010
Volume 2010:2 Pages 41 - 63
DOI: http://dx.doi.org/10.2147/CPAA.S8779
Tatyana Shamliyan
Division of Health Policy and Management, University of Minnesota School of Public Health and Minnesota Evidence-based Practice Center, Minneapolis, MN, USA
Abstract: We aimed to analyze trends in hospital admissions due to adverse drug effects between the years 2000 to 2007 among the elderly using the National Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project. We identified the discharges with the principal and all listed diagnoses related to adverse drug effects and associated hospital charges using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes. Between 2000 and 2007, 321,057 patients over 65 years were discharged with a principal diagnosis related to an adverse drug effect. Hospital charges were $5,329,276,300 or $666,159,537 annual cost. The number of discharges and total hospital charges did not change over the examined years, while mean charge per discharge increased on average by $1064 ± 384 per year. Total hospital charges for drug-induced gastritis with hemorrhage increased the most by $11,206,555 per year among those 66–84 years old and by $8,646,456 per year among those older than 85 years. During 2007, 791,931 elderly had adverse treatment effects among all listed diagnoses with hospital charges of $937,795,690. Effective drug management interventions are needed to improve safety of treatments in the elderly.
Keywords: adverse drug reaction reporting systems, aged, hospitalization, international classification of diseases
Other articles by Dr T Shamliyan
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Reporting of results of interventional studies by the information service of the National Institutes of Health
Erratum - Intracellular heavy metal nanoparticle storage
A case of cephalothin-associated urolithiasis
Scientific factors for assessing biosimilarity and drug interchangeability of follow-on biologics
Erratum
Human normal immunoglobulin in the treatment of primary immunodeficiency diseases
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




